---
figid: PMC9472513__nihms-1826411-f0001
figtitle: Discovery and biological evaluation of Phthalazines as novel non-kinase
  TGFB pathway inhibitors
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9472513
filename: nihms-1826411-f0001.jpg
figlink: /pmc/articles/PMC9472513/figure/F1/
number: F1
caption: TGFβ signaling pathway via SMAD-TGFβ ligand binds to transmembrane TGFβ type-II
  receptor (TGFβRII) and induces its phosphorylation, followed by autophosphorylation
  of TGFβ type-I (TGFβRI) receptor forming a heterotetrameric receptor complex with
  two type I receptors and two type II receptors. Activated TGFβRI initiates TGFβ/Smad
  signaling by phosphorylating receptor-associated Smads (R-Smads), Smad2, and Smad3.
  The activated R-Smads form a complex with Co-Smad and shuttles into the nucleus,
  binding to DNA at Smad-binding element in the promoter region of the TGFβ targeted
  gene. TGFβ receptor complex can also activate non-smad dependent pathways like Ras/ERK
  pathway, PI3K/AKT pathway, etc.
papertitle: Discovery and biological evaluation of Phthalazines as novel non-kinase
  TGFβ pathway inhibitors.
reftext: Anupreet Kharbanda, et al. Eur J Med Chem. ;223:113660-113660.
year: '2023'
doi: 10.1016/j.ejmech.2021.113660
journal_title: European journal of medicinal chemistry
journal_nlm_ta: Eur J Med Chem
publisher_name: ''
keywords: TGF-β pathway inhibitor | TGF-β inhibitor | Pthalazine derivatives | Non-kinase
  inhibitor | Cytokines
automl_pathway: 0.9546543
figid_alias: PMC9472513__F1
figtype: Figure
redirect_from: /figures/PMC9472513__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9472513__nihms-1826411-f0001.html
  '@type': Dataset
  description: TGFβ signaling pathway via SMAD-TGFβ ligand binds to transmembrane
    TGFβ type-II receptor (TGFβRII) and induces its phosphorylation, followed by autophosphorylation
    of TGFβ type-I (TGFβRI) receptor forming a heterotetrameric receptor complex with
    two type I receptors and two type II receptors. Activated TGFβRI initiates TGFβ/Smad
    signaling by phosphorylating receptor-associated Smads (R-Smads), Smad2, and Smad3.
    The activated R-Smads form a complex with Co-Smad and shuttles into the nucleus,
    binding to DNA at Smad-binding element in the promoter region of the TGFβ targeted
    gene. TGFβ receptor complex can also activate non-smad dependent pathways like
    Ras/ERK pathway, PI3K/AKT pathway, etc.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Smox
  - Mad
  - dpp
  - gbb
  - put
  - mav
  - ti
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - bsk
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Cdc42
  - Rho1
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR1
  - TGFBR2
  - TGFBR3
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CDC42
  - RHOA
---
